26226 PRS for enhanced coeliac disease (CED) 0 0 0 31 0 0 3 0 0 0 relative risk 302 0 0 0 0 0 0 Enhanced PRS Release: Polygenic risk score for the trait for every participant in the white, british, and unrelated UK Biobank testing set. 2022-03-30T00:00:00 2022-05-03T00:00:00 104605 104605 0 2 2 2
26227 PRS for standard coronary artery disease (CAD) 0 0 0 31 0 0 3 0 0 0 relative risk 301 0 0 0 0 0 0 Standard PRS Release: Polygenic score for the trait for all UK Biobank participants. External GWAS training data only. 2022-03-30T00:00:00 2022-05-03T00:00:00 486172 486172 0 2 2 2
26228 PRS for enhanced coronary artery disease (CAD) 0 0 0 31 0 0 3 0 0 0 relative risk 302 0 0 0 0 0 0 Enhanced PRS Release: Polygenic risk score for the trait for every participant in the white, british, and unrelated UK Biobank testing set. 2022-03-30T00:00:00 2022-05-03T00:00:00 104605 104605 0 2 2 2
26229 PRS for standard crohn's disease (CD) 0 0 1 31 0 0 3 0 0 0 relative risk 301 0 0 0 0 0 0 Standard PRS Release: Polygenic score for the trait for all UK Biobank participants. External GWAS training data only. 2022-03-30T00:00:00 2022-05-03T00:00:00 486172 486172 0 2 2 2
26229 PRS for standard crohn's disease (CD) 0 0 0 31 0 0 3 0 0 0 relative risk 301 0 0 0 0 0 0 Standard PRS Release: Polygenic score for the trait for all UK Biobank participants. External GWAS training data only. 2022-03-30T00:00:00 2022-05-03T00:00:00 486172 486172 0 2 2 2
26230 PRS for enhanced crohn's disease (CD) 0 0 1 31 0 0 3 0 0 0 relative risk 302 0 0 0 0 0 0 Enhanced PRS Release: Polygenic risk score for the trait for every participant in the white, british, and unrelated UK Biobank testing set. 2022-03-30T00:00:00 2022-05-03T00:00:00 104605 104605 0 2 2 2
26231 PRS for enhanced docosahexaenoic acid (DOA) 0 0 0 31 0 0 3 0 0 0 relative risk 302 0 0 0 0 0 0 Enhanced PRS Release: Polygenic risk score for the trait for every participant in the white, british, and unrelated UK Biobank testing set. 2022-03-30T00:00:00 2022-05-03T00:00:00 104605 104605 0 2 2 2
26232 PRS for standard epithelial ovarian cancer (EOC) 0 0 0 31 0 0 3 0 0 0 relative risk 301 0 0 0 0 0 0 Standard PRS Release: Polygenic score for the trait for all UK Biobank participants. External GWAS training data only. 2022-03-30T00:00:00 2022-05-03T00:00:00 486172 486172 0 2 2 2
26284 PRS for enhanced type 1 diabetes (T1D) 0 0 0 31 0 0 3 0 0 0 relative risk 302 0 0 0 0 0 0 Enhanced PRS Release: Polygenic risk score for the trait for every participant in the white, british, and unrelated UK Biobank testing set. 2022-03-30T00:00:00 2022-05-03T00:00:00 104605 104605 0 2 2 2
26285 PRS for standard type 2 diabetes (T2D) 0 0 0 31 0 0 3 0 0 0 relative risk 301 0 0 0 0 0 0 Standard PRS Release: Polygenic score for the trait for all UK Biobank participants. External GWAS training data only. 2022-03-30T00:00:00 2022-05-03T00:00:00 486172 486172 0 2 2 2
26286 PRS for enhanced type 2 diabetes (T2D) 0 0 0 31 0 0 3 0 0 0 relative risk 302 0 0 0 0 0 0 Enhanced PRS Release: Polygenic risk score for the trait for every participant in the white, british, and unrelated UK Biobank testing set. 2022-03-30T00:00:00 2022-05-03T00:00:00 104605 104605 0 2 2 2
26287 PRS for standard ulcerative colitis (UC) 0 0 1 31 0 0 3 0 0 0 relative risk 301 0 0 0 0 0 0 Standard PRS Release: Polygenic score for the trait for all UK Biobank participants. External GWAS training data only. 2022-03-30T00:00:00 2022-05-03T00:00:00 486172 486172 0 2 2 2
26287 PRS for standard ulcerative colitis (UC) 0 0 0 31 0 0 3 0 0 0 relative risk 301 0 0 0 0 0 0 Standard PRS Release: Polygenic score for the trait for all UK Biobank participants. External GWAS training data only. 2022-03-30T00:00:00 2022-05-03T00:00:00 486172 486172 0 2 2 2
26288 PRS for enhanced ulcerative colitis (UC) 0 0 1 31 0 0 3 0 0 0 relative risk 302 0 0 0 0 0 0 Enhanced PRS Release: Polygenic risk score for the trait for every participant in the white, british, and unrelated UK Biobank testing set. 2022-03-30T00:00:00 2022-05-03T00:00:00 104605 104605 0 2 2 2
26289 PRS for standard venous thromboembolic disease (VTE) 0 0 0 31 0 0 3 0 0 0 relative risk 301 0 0 0 0 0 0 Standard PRS Release: Polygenic score for the trait for all UK Biobank participants. External GWAS training data only. 2022-03-30T00:00:00 2022-05-03T00:00:00 486172 486172 0 2 2 2
26290 PRS for enhanced venous thromboembolic disease (VTE) 0 0 0 31 0 0 3 0 0 0 relative risk 302 0 0 0 0 0 0 Enhanced PRS Release: Polygenic risk score for the trait for every participant in the white, british, and unrelated UK Biobank testing set. 2022-03-30T00:00:00 2022-05-03T00:00:00 104605 104605 0 2 2 2